| Name | Title | Contact Details |
|---|
Jordan & Skala Engineers is a leading consulting-engineering firm that specializes in mechanical, electrical, and plumbing (MEP) engineering services. Founded in 1953 and headquartered in Norcross, GA, the company operates multiple regional design offices across the United States, allowing it to effectively meet the diverse needs of its clients. With a workforce of approximately 310 employees, Jordan & Skala Engineers is licensed to operate in all 50 states. The firm offers a wide range of services, including MEP engineering, structured cabling for communications, security system design, audio-visual solutions, and comprehensive energy services aimed at promoting sustainability. Additionally, the company conducts facility assessments to optimize existing buildings. Jordan & Skala Engineers is committed to engineering excellence, focusing on quality, safety, and strong client relationships through teamwork and innovative designs. The company has been recognized as a Top U.S. Workplace in 2023, underscoring its dedication to employee satisfaction and industry leadership.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
® 2023 FSNB, N.A. Member FDIC. Equal Housing Lender. Equal Opportunity Employer.
MFR Consultants, Inc. (MFR), a full-service management consulting firm headquartered in Philadelphia, PA, has provided end-to-end solutions in the areas of business analysis, information technology, project management and information governance for over 30 years.